Table 1 Characteristics of studies included in the systematic review and meta-analysis
Author (Year) | country | sample | Sample size (BPD/NO BPD) | GA(Weeks) | Metabolomics technique | NOS |
|---|---|---|---|---|---|---|
López-Hernández(2024) | Mexico | Urinary | 12/13 | < 34 | LC-MS/MS | 6 |
Course(2023) | United Kingdom | exhaled breath condensate | 34/110 | ≤ 34 | GCTOF-MS | 6 |
Wang(2022) | China | dried blood spots | 45/40 | < 33 | MS/MS | 7 |
Frazer(2022) | United States | Stool | 45/27 | < 28 | LC-MS/MS | 7 |
Ye(2022) | United States | dried blood spots | 355/395 | < 32 | LC-MS/MS | 6 |
Xu(2022) | China | tracheal aspirate | 23/5 | ≤ 34 | UPLC-TQ-MS | 6 |
Piersigilli(2019) | United States | tracheal aspirate | 44/24 | < 30 | LC-MS/MS | 7 |
Li(2019) | China | dried blood spots | 20/22 | < 32 | LC-MS/MS | 6 |
Huang(2019) | China | Urinary | 20/20 | < 32 | GC-MS | 6 |
Hendricks-Muñoz(2018) | United States | tracheal aspirate | 16/9 | < 32 | LC-MS/MS | 6 |
La Frano(2018) | United States | Umbilical cord blood | 10/10 | < 32 | GC-MS | 6 |
Pintus(2018) | Italy | Urinary | 7/11 | < 28 | 1 H-NMR | 5 |
Baraldi(2016) | Italy | Amniotic Fluid | 10/11 | 21–28 of pregnancy | UPLC-TQ-MS | 7 |
Fanos(2014) | Italy | Urinary | 18/18 | < 29 | NMR | 6 |
Rüdiger(2000) | Germany | tracheal aspirate | 10/15 | ≤ 32 | GC | 7 |